Tablet

Osimertinib 80mg

Osimertinib Mesylate

Tagrisso (Osimertinib 80mg) is a targeted anti-cancer medicine used to treat non-small cell lung cancer (NSCLC) in patients with specific EGFR mutations. It works by blocking the action of abnormal proteins that signal cancer cells to multiply, helping slow disease progression. Available in 40mg and 80mg tablet strengths for global pharmaceutical export.

Strengths

40mg / 80mg

Packing

30 tablets/bottle

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request Quotation WhatsApp

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition

Osimertinib Mesylate 40mg / 80mg

Dosage Form

Tablet

Available Strengths

40mg / 80mg

Packing

30 tablets/bottle

Route of Administration

Oral, with or without food

Dosage

80mg once daily until disease progression or unacceptable toxicity

Indications

Metastatic EGFR T790M mutation-positive NSCLC, first-line treatment of metastatic NSCLC with EGFR exon 19 deletions or L858R mutations, adjuvant therapy after tumor resection

Country of Origin

India (WHO-GMP Certified)

Storage

Store below 30°C

Shelf Life

36 months

Side Effects

Diarrhea, rash, dry skin, nail toxicity, stomatitis, fatigue, decreased appetite, QTc prolongation

Precautions

Monitor ECG and electrolytes for QTc prolongation; risk of ILD/pneumonitis; cardiomyopathy risk; confirm T790M mutation status for second-line use

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Tablet

Sorafenib 200mg

Sorafenib Tosylate

Soranib (Sorafenib 200mg) is an oral anti-cancer medicine that works by blocking abnormal protein signals that cause cancer cells to multiply. It helps stop or slow the spread of cancer in hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid carcinoma. Available for global pharmaceutical export with WHO-GMP certification.

200mg

Capsule

Lenalidomide 25mg

Lenalidomide

Lenalid (Lenalidomide 25mg) is an anti-cancer medicine that works by enhancing the immune system to attack cancer cells while preventing growth of new blood vessels within tumors. It is used for treatment of multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. Available in 5mg, 10mg, and 25mg capsule strengths for global pharmaceutical export.

5mg / 10mg / 25mg

Tablet

Imatinib 400mg

Imatinib Mesylate

First-in-class BCR-ABL tyrosine kinase inhibitor that transformed CML from a fatal disease into a chronically manageable condition, achieving complete cytogenetic response in over 80% of newly diagnosed chronic-phase patients. It also targets c-KIT and PDGFR, making it the standard first-line treatment for unresectable or metastatic GIST and Ph+ ALL. Cipla and Sun Pharma manufacture affordable Indian generics in both 100mg and 400mg tablet strengths exported to oncology programmes worldwide.

100mg / 400mg

Need bulk pricing for Osimertinib 80mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote